IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candid…
Biotechnology
US, South San Francisco [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer Group
Configuration
| Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 13,132.62 | 856.84 | 207.59 | -154.96 | 35.89 | 0.00 | 20.0382 | -0.38 | -1.0559 | -24.0147 | -0.09 | -0.08 | 6.8127 | - - | ||
| Maximum | - - | - - | - - | 458,604.00 | 65,349.00 | 25,407.00 | 99,050.00 | 5,305.00 | 0.01 | 1,336.3467 | 6.70 | 3.0051 | 85.3485 | 0.38 | 8.35 | 37.1953 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -1,175.00 | -56,335.00 | -1,185.00 | 0.00 | -164.8536 | -8.99 | -101.7758 | -1,444.7800 | -1.56 | -12.64 | 0.0007 | - - | ||
| SpringWorks Therapeutics, Inc. SWTX | 36.45 | -0.10 -0.27% | 3,512 vs. 986 | 2,711.00 | 21.00 | -87.00 | -79.00 | -982.00 | -1.1800 | -10.0500 | 0.0000 | 0.9081 | -4.1600 | -0.1540 | -0.1330 | 6.5602 | 74.00 | ||
| Revolution Medicines, Inc. RVMD | 55.13 | -2.24 -3.90% | 1,944 vs. 1,156 | 9,273.00 | 0.00 | -116.00 | -163.00 | -1,253.00 | -0.7000 | -11.2467 | 0.0000 | 0.0000 | 0.0000 | -0.0672 | -0.0608 | 18.1763 | 168.00 | ||
| IDEAYA Biosciences, Inc. IDYA | 26.64 | -2.83 -9.60% | 1,190 vs. 713 | 2,302.00 | 0.00 | -39.00 | -45.00 | -387.00 | -0.5300 | -20.1760 | 0.0000 | 0.0000 | 0.0000 | -0.0423 | -0.0412 | 27.9963 | 86.00 | ||
| MoonLake Immunotherapeutics MLTX | 48.83 | -3.67 -6.99% | 401 vs. 301 | 3,079.00 | 0.00 | -13.00 | -15.00 | -130.00 | -0.2200 | -55.6575 | 0.0000 | 0.0000 | 0.0000 | -0.0252 | -0.0242 | 61.5621 | 63.00 | ||
| Cerevel Therapeutics Holdings, Inc. CERE | 44.96 | 0.33 0.74% | 15,033 vs. 2,056 | 8,191.00 | 0.00 | -131.00 | -119.00 | -1,532.00 | -0.7300 | -14.5661 | 0.0000 | 0.0000 | 0.0000 | -0.2337 | -0.1170 | 10.1215 | 182.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.